Micropaque Scanner (Barium Sulfate)

Barium sulfate consists of dense, insoluble particles that absorb X‑ray photons. When the suspension coats the lining of the gastrointestinal tract, it creates a radiopaque layer that blocks X‑rays, producing a stark contrast between the barium‑filled lumen and surrounding soft tissues on radiographs. This contrast improves the visibility of structural details during imaging.

The dose of Micropaque Scanner is determined by the prescribing physician based on the specific imaging procedure, patient age, weight, and clinical indication. Healthcare providers select the appropriate volume and concentration to achieve optimal contrast while considering patient safety. Exact dosing information should always be obtained from the treating clinician.

Use of Micropaque Scanner during pregnancy or lactation is reserved for situations where the diagnostic benefit outweighs potential risk to the fetus or infant. Barium sulfate does not cross the placenta in significant amounts, but the procedure may cause discomfort. Physicians should evaluate each case individually and discuss alternatives when possible.

To order Micropaque Scanner, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements if applicable) and assist with import documentation.

The primary alternative to barium sulfate is iodinated contrast media, which are water‑soluble and used for both gastrointestinal and vascular imaging. Barium provides superior mucosal coating and higher radiodensity for GI studies, but it cannot be used when the bowel is perforated. Iodinated agents are safer in cases of suspected perforation and can be administered intravenously, whereas barium is limited to oral or rectal routes.

Micropaque Scanner should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperature fluctuations. Keep the container tightly sealed when not in use to maintain suspension stability. Follow local regulations for handling and disposal of contrast media residues.

Micropaque Scanner is supplied as a powder that is reconstituted with water to form a suspension. It can be administered orally as a drink or via a rectal enema, depending on the imaging study. The prepared suspension should be mixed thoroughly to ensure uniform consistency before the patient ingests or receives it under the supervision of qualified medical personnel.

The most serious risks include severe allergic reactions or anaphylaxis, which require immediate medical attention, and gastrointestinal complications such as bowel obstruction or perforation, especially in patients with existing strictures, recent surgery, or inflammatory disease. Prompt recognition of symptoms and appropriate clinical management are essential to mitigate these risks.

Micropaque Scanner should be avoided in patients with known hypersensitivity to barium sulfate or other contrast agents, those with confirmed gastrointestinal obstruction, perforation, or severe strictures, and individuals who have had recent gastrointestinal surgery unless cleared by a physician. Caution is also advised for patients with severe renal impairment, and its use in pregnancy should be limited to essential diagnostic situations.